Copyright Reports & Markets. All rights reserved.

Global Neuromuscular Blocking Drug Market Research Report 2021

Request for Sample of this report
Buy now

1 Neuromuscular Blocking Drug Market Overview

  • 1.1 Product Overview and Scope of Neuromuscular Blocking Drug
  • 1.2 Neuromuscular Blocking Drug Segment by Type
    • 1.2.1 Global Neuromuscular Blocking Drug Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Non-polarizing Agents
    • 1.2.3 Depolarizing Agents
  • 1.3 Neuromuscular Blocking Drug Segment by Application
    • 1.3.1 Neuromuscular Blocking Drug Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Pharmacy
    • 1.3.5 Others
  • 1.4 Global Neuromuscular Blocking Drug Market Size Estimates and Forecasts
    • 1.4.1 Global Neuromuscular Blocking Drug Revenue 2016-2027
    • 1.4.2 Global Neuromuscular Blocking Drug Sales 2016-2027
    • 1.4.3 Neuromuscular Blocking Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neuromuscular Blocking Drug Market Competition by Manufacturers

  • 2.1 Global Neuromuscular Blocking Drug Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Neuromuscular Blocking Drug Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Neuromuscular Blocking Drug Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Neuromuscular Blocking Drug Manufacturing Sites, Area Served, Product Type
  • 2.5 Neuromuscular Blocking Drug Market Competitive Situation and Trends
    • 2.5.1 Neuromuscular Blocking Drug Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Neuromuscular Blocking Drug Players Market Share by Revenue
    • 2.5.3 Global Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neuromuscular Blocking Drug Retrospective Market Scenario by Region

  • 3.1 Global Neuromuscular Blocking Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Neuromuscular Blocking Drug Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Neuromuscular Blocking Drug Market Facts & Figures by Country
    • 3.3.1 North America Neuromuscular Blocking Drug Sales by Country
    • 3.3.2 North America Neuromuscular Blocking Drug Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Neuromuscular Blocking Drug Market Facts & Figures by Country
    • 3.4.1 Europe Neuromuscular Blocking Drug Sales by Country
    • 3.4.2 Europe Neuromuscular Blocking Drug Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Neuromuscular Blocking Drug Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Neuromuscular Blocking Drug Sales by Region
    • 3.5.2 Asia Pacific Neuromuscular Blocking Drug Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Neuromuscular Blocking Drug Market Facts & Figures by Country
    • 3.6.1 Latin America Neuromuscular Blocking Drug Sales by Country
    • 3.6.2 Latin America Neuromuscular Blocking Drug Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Neuromuscular Blocking Drug Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Neuromuscular Blocking Drug Sales by Country
    • 3.7.2 Middle East and Africa Neuromuscular Blocking Drug Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Neuromuscular Blocking Drug Historic Market Analysis by Type

  • 4.1 Global Neuromuscular Blocking Drug Sales Market Share by Type (2016-2021)
  • 4.2 Global Neuromuscular Blocking Drug Revenue Market Share by Type (2016-2021)
  • 4.3 Global Neuromuscular Blocking Drug Price by Type (2016-2021)

5 Global Neuromuscular Blocking Drug Historic Market Analysis by Application

  • 5.1 Global Neuromuscular Blocking Drug Sales Market Share by Application (2016-2021)
  • 5.2 Global Neuromuscular Blocking Drug Revenue Market Share by Application (2016-2021)
  • 5.3 Global Neuromuscular Blocking Drug Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Hikma Pharmaceuticals
    • 6.1.1 Hikma Pharmaceuticals Corporation Information
    • 6.1.2 Hikma Pharmaceuticals Description and Business Overview
    • 6.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Hikma Pharmaceuticals Product Portfolio
    • 6.1.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 6.2 Merck
    • 6.2.1 Merck Corporation Information
    • 6.2.2 Merck Description and Business Overview
    • 6.2.3 Merck Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Merck Product Portfolio
    • 6.2.5 Merck Recent Developments/Updates
  • 6.3 Novartis
    • 6.3.1 Novartis Corporation Information
    • 6.3.2 Novartis Description and Business Overview
    • 6.3.3 Novartis Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Novartis Product Portfolio
    • 6.3.5 Novartis Recent Developments/Updates
  • 6.4 Bayer
    • 6.4.1 Bayer Corporation Information
    • 6.4.2 Bayer Description and Business Overview
    • 6.4.3 Bayer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bayer Product Portfolio
    • 6.4.5 Bayer Recent Developments/Updates
  • 6.5 Pfizer
    • 6.5.1 Pfizer Corporation Information
    • 6.5.2 Pfizer Description and Business Overview
    • 6.5.3 Pfizer Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Pfizer Product Portfolio
    • 6.5.5 Pfizer Recent Developments/Updates
  • 6.6 AbbVie
    • 6.6.1 AbbVie Corporation Information
    • 6.6.2 AbbVie Description and Business Overview
    • 6.6.3 AbbVie Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 AbbVie Product Portfolio
    • 6.6.5 AbbVie Recent Developments/Updates
  • 6.7 GSK
    • 6.6.1 GSK Corporation Information
    • 6.6.2 GSK Description and Business Overview
    • 6.6.3 GSK Neuromuscular Blocking Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 GSK Product Portfolio
    • 6.7.5 GSK Recent Developments/Updates

7 Neuromuscular Blocking Drug Manufacturing Cost Analysis

  • 7.1 Neuromuscular Blocking Drug Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Neuromuscular Blocking Drug
  • 7.4 Neuromuscular Blocking Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Neuromuscular Blocking Drug Distributors List
  • 8.3 Neuromuscular Blocking Drug Customers

9 Neuromuscular Blocking Drug Market Dynamics

  • 9.1 Neuromuscular Blocking Drug Industry Trends
  • 9.2 Neuromuscular Blocking Drug Growth Drivers
  • 9.3 Neuromuscular Blocking Drug Market Challenges
  • 9.4 Neuromuscular Blocking Drug Market Restraints

10 Global Market Forecast

  • 10.1 Neuromuscular Blocking Drug Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Neuromuscular Blocking Drug by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Neuromuscular Blocking Drug by Type (2022-2027)
  • 10.2 Neuromuscular Blocking Drug Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Neuromuscular Blocking Drug by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Neuromuscular Blocking Drug by Application (2022-2027)
  • 10.3 Neuromuscular Blocking Drug Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Neuromuscular Blocking Drug by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Neuromuscular Blocking Drug by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Non-polarizing Agents
    Depolarizing Agents

    Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Hikma Pharmaceuticals
    Merck
    Novartis
    Bayer
    Pfizer
    AbbVie
    GSK

    Buy now